自体网状皮片与异种(猪)脱细胞真皮基质复合移植的临床应用

目的：探讨1：3自体网状皮片与异种（猪）脱细胞真皮基质复合移植的可行性。方法：选择9例烧伤及瘢痕患者，在Ⅲ度烧伤创面行切痂术或瘢痕切除术后的创面上移植异种（猪）脱细胞真皮基质，摊平固定后，在支架上再植1：3网状自体刃厚皮片，表面再覆盖辐照猪皮。结果：9例复合移植皮肤全部成活，临床效果满意。结论：1：3自体网状刃厚片可以与异种（猪）脱细胞真皮基质复合移植，同时将自体皮扩增3倍，成活后的复合网状皮片有相当于中厚皮片或者全厚皮片移植的效果。     

异种(猪)脱细胞真皮基质与头皮薄皮片复合移植

目的探索异种(猪)脱细胞真皮基质与头皮薄皮片复合移植在整形修复方面应用的可行性.方法将制备好的异种(猪)脱细胞真皮基质移植于烧伤切痂、肉芽及瘢痕切除的创面上,4～5 d后再移植自体头皮薄皮片,并观察其成活率,以及创面修复后的质量.结果 15例25个创面,脱细胞真皮基质的成活率(96.40±2.60)%,头皮薄皮片的成活率(97.44±3.50)%,创面愈合后皮肤的颜色与正常皮肤近似,外观平整,弹性良好,无明显的瘢痕增生,相当或接近于自体大张中厚皮片移植的修复效果.结论异种(猪)脱细胞真皮基质与自体头皮薄皮片复合移植,成活率高,整复效果较为满意,头皮供区可反复供皮而不留瘢痕及影响头发生长,是修复深度烧伤及瘢痕切除后创面的可行手术方法.     

不同种属脱细胞真皮基质与自体刃厚皮复合移植近期效果的对比研究

目的　对比研究异体和异种脱细胞真皮基质 (acellular dermal matrix,ADM)与自体刃厚皮复合移植 ,应用在烧伤创面的近期效果 ,为全层皮肤缺损的无瘢痕修复寻求理想的皮肤替代物。　方法　 2 0 0 1年 9月～ 2 0 0 3年 6月 ,以两种 ADM分别与自体刃厚皮复合移植于 18例 度烧伤患者的切痂创面 ,以单纯自体中厚皮移植作对照 ,通过术后 2周自体皮成活率、术后 8周自体皮收缩率和温哥华瘢痕评分比较移植效果。　结果　三种移植方式术后 2周皮片成活率组间比较无差异 (P>0 .0 5 ) ;其中 14例患者术后第 8周随访 ,未见明显排斥反应 ,三种移植方式术后 8周皮片收缩率和瘢痕评分组间比较无差异 (P>0 .0 5 )。　结论　异体和异种 ADM在临床上具有相近的效果 ,均能用于受皮者的皮肤重建。     

异体脱细胞真皮基质与自体皮片复合移植的临床应用

目的:探讨异体脱细胞真皮基质与自体皮片复合移植修复大面积深度烧伤及瘢痕切除后皮肤缺损创面及其愈合后皮肤的外形和功能。方法:应用异体脱细胞真皮基质与自体刃厚皮片组成复合皮移植,以自体刃厚皮片移植作为对照,采用一步移植法治疗切痂后大面积深度烧伤创面及瘢痕切除后皮肤缺损共56例患者60处创面,观察术后皮片的成活情况、外形及功能恢复情况并随访。结果:60处创面全部愈合,移植皮片生长良好,瘢痕增生不明显,未见明显挛缩,皮肤弹性较好。在6～12个月的观察期内,自体刃厚皮片与异体脱细胞真皮基质复合移植后,功能和形态优于单纯自体刃厚皮片移植;随访2年复合移植未发现明显的排异反应。结论:异体脱细胞真皮基质与自体皮片复合移植修复大面积深度烧伤及瘢痕切除后皮肤缺损创面愈合良好,无瘢痕增生,皮肤外观功能满意,无排异反应。     

异体脱细胞真皮基质与自体皮片复合移植的临床应用

目的:探讨异体脱细胞真皮基质与自体皮片复合移植修复大面积深度烧伤及瘢痕切除后皮肤缺损创面及其愈合后皮肤的外形和功能。方法:应用异体脱细胞真皮基质与自体刃厚皮片组成复合皮移植,以自体刃厚皮片移植作为对照,采用一步移植法治疗切痂后大面积深度烧伤创面及瘢痕切除后皮肤缺损共56例患者60处创面,观察术后皮片的成活情况、外形及功能恢复情况并随访。结果:60处创面全部愈合,移植皮片生长良好,瘢痕增生不明显,未见明显挛缩,皮肤弹性较好。在6～12个月的观察期内,自体刃厚皮片与异体脱细胞真皮基质复合移植后,功能和形态优于单纯自体刃厚皮片移植;随访2年复合移植未发现明显的排异反应。结论:异体脱细胞真皮基质与自体皮片复合移植修复大面积深度烧伤及瘢痕切除后皮肤缺损创面愈合良好,无瘢痕增生,皮肤外观功能满意,无排异反应。     

脱细胞真皮基质与自体刃厚皮片复合移植的临床及组织学观察

目的 观察异体脱细胞真皮基质与自体刃厚皮片复合移植修复创面的中、长期临床效果,并做组织学观察.方法 选取23例接受异体脱细胞真皮基质加自体刃厚皮片复合移植的患者,于术后3、6、12、18个月进行临床随访,并作组织学观察.结果 移植后3、6、12、18个月,复合皮表面平滑,无明显瘢痕增生及色素沉着现象,柔软有弹性,关节部位活动自如.组织学观察接近正常皮肤形态.结论 异体脱细胞真皮基质与自体刃厚皮片复合移植后愈合创面表面光滑,平整柔软,无明显挛缩,关节活动自如,未见明显排汗现象,可作为修复创面的良好选择.     

去细胞异体真皮、去细胞猪真皮和自体刃厚皮移植在临床中的应用

目的观察去细胞异体真皮或去细胞猪真皮加自体刃厚皮移植在深度烧伤和整形外科中的应用效果。方法采用去细胞异体真皮或我们研制的去细胞猪真皮加自体刃厚皮移植的方法,修复各种创面119例次,比较不同创面的植皮成活率,观察应用不同部位的皮肤覆盖去细胞异体真皮或去细胞猪真皮与植皮成活的关系,并对部分病例进行了组织学观察和随访。结果削痂、切痂和切瘢创面植皮成活率分别为(93．4％±3．1)％、(92．1±4．6)％和(94．5±3．8)％,三者间差异无显著意义;去细胞异体真皮加自体刃厚皮移植与去细胞猪真皮加自体刃厚皮移植,二者植皮成活率差异无显著意义。躯干、四肢自体刃厚皮覆盖的去细胞异体真皮或去细胞猪真皮,植皮成活率分别为(93．1±4．8)％、(89．0±6．2)％,而应用刃厚头皮或自体微粒皮加异体皮覆盖的去细胞异体真皮或去细胞猪真皮,植皮成活率明显下降(P<0．05或0．01)。组织学观察,术后19个月时表皮、真皮形态正常,胶原纤维排列规则,未见胶原纤维明显增生和瘢痕化,无皮肤附件。成活的复合移植皮肤,与邻近正常肤色近似,色素沉着轻,无明显皱缩,触之软,活动度好。结论去细胞异体真皮或去细胞猪真皮加自体刃厚皮移植修复深度烧伤创面或切瘢后创面不失为一种较理想的材料。     

真皮模板对大鼠创面组织生物力学顺应性的影响

目的　探讨真皮模板对创伤修复过程中创面皮肤组织生物力学顺应性的影响。方法将144只SD大鼠造成全层皮肤组织缺损,根据是否行自体皮移植及移植皮厚度随机分为开放创面组(创面不植皮,包扎后自然愈合)、全厚皮组(创面移植自体全厚皮)、刃厚皮组(创面移植自体刃厚皮)、复合移植组(创面移植脱细胞真皮基质 自体刃厚皮),每组每时相点6只大鼠。分别于术后1、2、4、6、12、20周取创面组织标本,用Instron生物力学测定仪测定各组创面组织的生物力学顺应性;用亲和素生物素复合物(ABC)法检测各组真皮成纤维细胞中α平滑肌肌动蛋白(αSMA)的表达量。结果　术后4—20周复合移植组创面组织的力学顺应性优于开放创面组和刃厚皮组(P<0 .05), 较全厚皮组差(P<0 .05).术后4周复合移植组αSMA的阳性表达率为(7. 53±0. 98)%,低于开放创面组(26. 99±2. 90)%和刃厚皮组[ (12. 18±2. 79)%,P<0 .01], 高于全厚皮组。　结论　真皮模板可改善组织的力学顺应性, 这可能是其影响创面愈合过程中瘢痕形成、改善愈合质量的机制之一。     

异种(猪)脱细胞真皮基质与自体皮复合移植的临床应用

目的：观察基底良好的深度创面用异种（猪）脱细胞真皮基质与自体皮复合移植的临床疗效。方法：2000年1月-2002年2月用异种（猪）真皮基质与自体薄片复合移植（二步法）修复基底良好的深度创面52例。结果：37例（71.1%）植皮完全成活，15例（28.9%）植皮95%以上成活，无一例补植皮。随访3-6个月复合移植皮肤颜色、质地基本接近于正常皮肤，瘢痕增生不明显。结论：异种（猪）真皮基质可推广应用于修复基底良好的深度创面的复合移植。     

脱细胞真皮基质在胸部瘢痕疙瘩治疗中的应用

1998年～2004年,我们应用脱细胞真皮基质一期覆盖胸部瘢痕疙瘩切除后的创面12例,二期应用自体刃厚皮片移植于脱细胞真皮基质上,效果满意,报告如下.     

复合皮移植修复烧伤功能部位创面疗效评价

目的探讨脱细胞同种异体真皮与自体刃厚皮复合移植修复深度烧伤功能部位创面的疗效。方法 2002年6月-2008年12月,收治30例烧伤及瘢痕整形患者共42个创面。男25例,女5例;年龄3～52岁,中位年龄31岁。烧伤24例35个创面,其中深Ⅱ度23个创面,Ⅲ度12个创面;病程3～45 d,平均24 d。瘢痕整形6例7个创面;病程9～21 d,平均16 d。42个创面分别位于颈部2个,手部4个,前臂及肘部8个,肩部3个,腘窝6个,膝部4个,小腿及足踝部15个。彻底清创、削痂及切除瘢痕后,创面范围为10 cm×10 cm～30 cm×20 cm。采用一步法将脱细胞同种异体真皮与自体刃厚皮复合移植修复创面。结果术后27例39个(92.9%)创面复合皮移植完全成活;3例3个(7.1%)创面复合皮部分坏死,分别经换药和自体皮片移植术后愈合。患者均获随访,随访时间30～34个月,平均32个月。复合皮有轻度色素沉着,外观平整,质地柔软,弹性好,皮肤耐磨;复合皮无挛缩及瘢痕增生,功能部位活动正常。刃厚皮供皮区未见瘢痕增生。结论脱细胞同种异体真皮与自体刃厚皮复合移植修复功能部位深度烧伤及瘢痕整形创面,可获得良好外形及功能。     

Depth of the graft bed influences split-skin graft contraction

Contraction of a split-thickness skin graft used for coverage of large defects remains a great problem in plastic, burn and reconstructive surgery. In this study we evaluated healing of split-thickness skin grafts transplanted in wounds on the subcutaneous fat and muscle fascia in pigs. Four young domestic female pigs were included in the study, and the contraction was measured planimetrically during a 3-months' follow-up. At the end of the study the scar tissue was histologically assessed. From day 42 till the end of the study grafts transplanted on the muscle fascia were significantly more contracted than grafts on the subcutaneous fat without (p < 0.001) and with (p < 0.005, unpaired t-test) correction for the growth of the animal. The histological assessment showed that after 3 months the regenerated dermal tissue in the muscle fascia wounds was thicker, and less remodeled (higher tissue cellularity and thinner collagen bundles). In conclusion, in pigs, split-thickness skin grafts transplanted into deeper wounds contract more, and scar tissue maturation seems to last longer.     

Use of porcine acellular dermal matrix as a dermal substitute in rats

OBJECTIVE: To examine porcine acellular dermal matrix (ADM) as a xenogenic dermal substitute in a rat model. SUMMARY BACKGROUND DATA: Acellular dermal matrix has been used in the treatment of full-thickness skin injuries as an allogenic dermal substitute providing a stable wound base in human and animal studies. METHODS: Xenogenic and allogenic ADMs were produced by treating porcine or rat skin with Dispase and Triton X-100. Full-thickness skin defects (225 mm2) were created on the dorsum of rats (n = 29), porcine or rat ADMs were implanted in them, and these were overlain with ultrathin split-thickness skin grafts (STSGs). In two adjacent wounds, 0.005- or 0.017-inch-thick autografts were implanted. In other experiments, the antimicrobial agent used during ADM processing (azide or a mixture of antibiotics) and the orientation of the implanted ADM (papillary or reticular side of ADM facing the STSG) were studied. Grafts were evaluated grossly and histologically for 30 days after surgery. RESULTS: Significant wound contraction was seen at 14, 20, and 30 days after surgery in wounds receiving xenogenic ADM, allogenic ADM, and thin STSGs. Contraction of wounds containing xenogenic ADM was significantly greater than that of wounds containing allogenic ADM at 30 days after surgery. Graft take was poor in wounds containing xenogenic ADM and moderately good in those containing allogenic ADM. Wound healing was not significantly affected by the antimicrobial agent used during ADM preparation or by the ADM orientation. CONCLUSION: Dispase-Triton-treated allogenic ADM was useful as a dermal substitute in full-thickness skin defects, but healing with xenogenic ADM was poor.     

Long-term outcome of xenogenic dermal matrix implantation in immunocompetent rats

BACKGROUND: Acellular dermal matrix (ADM) has been used successfully in the treatment of full-thickness skin injuries as an allogenic dermal substitute. To assess the efficacy of xenogenic ADM in such wounds, we examined the long-term wound healing and immunological responses to porcine ADM in a rat model. MATERIALS AND METHODS: Xenogenic and allogenic ADMs were produced by treating porcine (fresh or cryopreserved) or rat skin with dispase and Triton X-100. Full-thickness skin defects on the rat dorsum were implanted with porcine or rat ADMs and overlaid with split-thickness skin grafts (STSGs). Wounds were evaluated grossly and immunologically at 1, 6, and 12 months after surgery. RESULTS: Extensive wound contraction was seen in wounds implanted with porcine ADM, but healing was significantly (P < 0.01) better in the rat ADM or STSG groups at 6 and 12 months postsurgery. Sera obtained from porcine ADM-implanted rats reacted strongly with porcine ADM and specifically with the papillary dermis and basal lamina. One month postsurgery, extensive inflammation but few intact mast cells were seen in wounds implanted with porcine ADM and significant (P < 0.02) levels of residual porcine ADM were detectable immunologically. Little inflammation was evident in the STSG or rat ADM groups at any time. Significant lymphocyte proliferation (P < 0.05) occurred in the 6- and 12-month groups in response to porcine, but not rat, ADM. CONCLUSIONS: In wounds implanted with xenogenic ADM, a short-lived acute inflammatory response, long-lasting humoral and cell-mediated immune responses, and generally poor wound healing were observed.     

Prospective study of the effect of the recipient bed on skin graft survival after thermal injury

There is little objective information available on the influence of the graft bed on skin graft survival after early excision of the burn wound. Yet surgeons are faced daily with the question of whether to graft onto fat after sequential excision of the burn eschar, or whether to excise deeper and graft onto muscle or fascia. To answer this question 71 consecutive patients were enrolled in a prospective study of the effect of the recipient graft bed on skin graft survival after thermal injury. These patients included 25 pediatric patients (mean TBSA, 19.1%) and 46 adult patients (mean TBSA, 25.1%). Overall mean +/- SD graft take was 94 +/- 11%. No difference between the per cent of graft take of grafts placed on fat (94 +/- 11%) versus fascia (85 +/- 19%) was found (p = 0.21). The results of this prospective study indicate that when the burn is too deep to graft onto dermis, there does not appear to be any advantage to routinely performing a fascial excision to avoid grafting onto a fat or mixed fat/dermal recipient graft bed, since the percentage of graft take and the incidence of regrafting are similar between these groups.     

Allogeneic skin substitutes applied to burns patients

Early re-surfacing of burn wounds remains the ideal but is limited by the availability of skin graft donor sites. Cultured grafts overcome these problems and autologous keratinocytes can be grown in culture and placed on a dermal substitute, but this results in delay and requires two operations. We developed an organotypic skin substitute, which achieves cover in one procedure, and have previously found allogeneic cell survival up to 2.5 years after grafting onto clean elective wounds (tattoo removal). Here, we report a short series using the same model applied to burns patients with less than 20% total body surface area affected. The skin substitutes consisted of allogeneic dermal fibroblasts embedded in a collagen gel overlain with allogeneic epidermal keratinocytes, and were grafted to patients with tangentially excised burns. A side-by-side comparison with meshed split-thickness autografts was performed. No grafts became infected. The allogeneic skin substitute showed little effective take at 1 week, and by 2 weeks only small islands of keratinocytes survived. These sites were subsequently covered with meshed split-thickness autograft, which took well. It is concluded that further development of this model is needed to overcome the hostile wound bed seen in burns patients.     

Charles procedure for lymphedema: A warning

Five patients with lower extremity lymphedema treated by subcutaneous excision and split-thickness graft resurfacing (from the opposite extremity) have been followed up. Three of these patients underwent amputation of the leg because of exophytic changes within the grafted skin, chronic cellulitis and skin breakdown. Resurfacing with a split-thickness graft causes a deformity that is significantly worse than the original lymphedema.In the Charles procedure (subcutaneous and deep fascial excision followed by full-thickness grafts), deep muscle fascia should be excised with the subcutaneous tissue and the extremity resurfaced with more durable full-thickness grafts taken from the excised tissue. However, the risks of graft failure should be considered.Over the past 9 years, 25 patients with lymphedema have been successfully managed by staged subcutaneous excision beneath flaps. This procedure safely provides consistent reduction in size, improvement in function and very satisfactory esthetic results. In the author's opinion the Charles procedure is therefore preferred for treating lymphedema of the extremity.     

Skin regeneration for children with burn scar contracture using autologous cultured dermal substitutes and superthin auto-skin grafts: preliminary clinical study

We have evaluated a novel treatment of burn scar contracture in children. This method involves the application of an autologous cultured dermal substitute (CDS), followed by a graft of superthin split-thickness skin. In the first operation, the autologous CDS was applied to the skin defect that had occurred after releasing the scar contracture. In the second operation, a superthin thickness skin graft (4 approximately 6/1000 inches) was applied 5 approximately 12 days after the first operation. The autologous CDS was applied to 10 sites of 5 children. On 8 sites, the skin grafts were contracted to some extent at an early stage. However, these skin grafts were stretched gradually to a range from 60% to 100% of an original size. At 2 sites, the skin grafts had stretched from 110% to 130% of the original size. This strategy may be useful for the treatment of burn scar contracture in children.